News & Media
Exposing the Hidden Costs Behind Prescriptions
Podcast: The Business of Pharmacy with Mike Koelzer, Mike Koelzer and Pramod John
10/02/2023
Read More ->
Why Better Outcomes Cost Less
Seminar for Consilium Scientific, an independent non-profit organization improving clinical research through scientific rigor and transparency, Leeza Osipenko and Pramod John
09/14/2023
Read More ->
Perspectives on Cancer Therapy Development
The Asco Post, William J.M. Hrushesky, MD, FACP, ABIM IM & MO, VIVIO Clinical Advisory Board
09/10/2023
Read More ->
The Accelerated Approval Program for Cancer Drugs — Finding the Right Balance
The New England Journal of Medicine, Bishal Gyawali, M.D., VIVIO Clinical Advisory Board
09/09/2023
Read More ->
Alex Jung: It’s time to Think Differently about Specialty Drugs
Formulary Watch, Denise Myshko
06/21/2023
Read More ->
How Mark Cuban’s Cost Plus Drugs has been turned into an insurance benefit
Becker's Payer Issues, Jakob Emerson
06/20/2023
Read More ->
Why biosimilars will fail: and what we can do about it
Benefits PRO, Pramod John
05/04/2023
Read More ->
Patients Often Lose in the Battle between Pharma and PBMs
Formulary Watch, Denise Myshko
05/02/2023
Read More ->
Validation Institute Independently Certifies VIVIO Delivered 39% Lower PMPM Costs Year-Over-Year
VIVIO uses data to ensure every patient is on an effective and affordable therapy
News Release, VIVIO
03/27/2023
Read More ->
Mark Cuban Cost Plus Drug Company and VIVIO team up to help employers and health plans stop overpaying for specialty drugs
News Release, VIVIO & Cost Plus Drugs
10/18/2022
Read More ->
Bhargav Raman, MD, VIVIO VP, Clinical Product, participates in IBD Shared Value Initiative
News Release, VIVIO
07/30/2022
Read More ->
Consulting industry leader, Lisa Zeitel, joins VIVIO Advisory Board
News Release, VIVIO
09/20/2022
Read More ->
Compliance Issues with Alternative Funding Programs for Specialty Drugs
News Release, VIVIO
06/29/2022
Read More ->
How Data and Analytics can be Leveraged to Manage Specialty Drugs
Formulary Watch, Denise Myshko
04/27/2022
Read More ->
VIVIO Adds Retail Industry Leader, Marcus Osborne, to Advisory board as Consumers Need More Effective Specialty Drug Therapies at Lower Costs
News Release, VIVIO
03/30/2022
Read More ->
Substandard Control Arms in Clinical Trials for Prostate Cancer
Journal of Clinical Oncology, Van Wambeke et. al.
02/22/2022
Read More ->
What You Need to Know About Specialty Pharmacy Formularies and Rebating
Relentless Health Value, Stacey Richter & Pramod John
02/03/2022
Read More ->
Actionable Surprises About the Efficacy and Effectiveness of Specialty Pharmaceuticals
Relentless Health Value, Stacey Richter & Pramod John
01/27/2022
Read More ->
Healthcare’s Asymmetry of Information
Healthcare Upside/Down, Nick van Terheyden & Pramod John
01/21/2022
Read More ->
Overhauling the Specialty Drug Industry
Speaking of Today Show, Apurv Gupta, Stephanie Feals & Pramod John
10/21/2021
Read More ->
Access to cancer medicines deemed essential by oncologists in 82 countries
The Lancet Oncology, Bishal Gyawali
09/21/2021
Read More ->
2021 Shown to be Terrible Year for Overturns of Accelerated FDA Approvals in Oncology.
thebmj, Bishal Gyawali
08/04/2021
Read More ->
VIVIO Adds Industry Leaders to Advisory Board as Demand Increases for Transparent and Innovative Specialty Drug Management
Article from prweb, Chris Crawford
07/22/2021
Read More ->
Increased vial size of Blockbuster drug Keytruda drives billions of waste
Journal of the National Cancer Institute, Daniel Goldstein, et. al.
07/21/2021
Read More ->
Biosimilars in Oncology: A Payor, Provider, and Community/C-Suite Perspective
CE Synergy Panel Discussion, Kevin Knopf
05/06/2021
Read More ->
The Burden of Out-of-Pocket Costs for NSCLC Care
Article in MedPage Today, Bishal Gyawali
04/09/2021
Read More ->
When Enthusiasm for New Cancer Drugs Is Premature
Interview in Oncology Times, Bishal Gyawali
04/08/2021
Read More ->
Cutting Costs: CHG Healthcare Carves Out Specialty Pharmacy
Catalyst for Payment Reform Webinar, Anne Hopkins, CHG Healthcare & Pramod John
11/12/2020
Read More ->
Case Study: Dean Foods Attempts Savings via Specialty Carve-out
The Centers for Biosimilars, Skylar Jeremias
10/17/2020
Read More ->
Target and Tame the Drug Spend Monster
Podcast of Pramod John , with David Saltzman
06/22/2020
Read More ->
VIVIO Biosimilars Case Study
Carving out Specialty Pharmacy and Using Biosimilars to Control Specialty Spend, By Gallagher
05/18/2020
Read More ->
The Secret Behind High Drug Costs
Podcast of Pramod John , By The Commonwealth Club
10/17/2019
Read More ->
VIVIO Wins Coveted EHIR Innovator Award
VIVIO, a specialty drug management company, won one of two innovator awards offered by Employer Health Innovation Roundtable, News Release
10/10/2019
Read More ->
Using Real-World Data The Right Way
Interview in First Report Managed Care, Pramod John
09/01/2019
Read More ->
This spoonful of sugar will help the medicine go down!
Podcast interview with Michael Andrade, PRAMOD JOHN
07/23/2019
Read More ->
Are Specialty Pharmacy Treatment Decisions Really Evidence-Based?
quoted in article by David Wild, PRAMOD JOHN
07/19/2019
Read More ->
National Alliance of Healthcare Purchaser Coalitions, 2019 Leadership Summit
06/26/2019
Read More ->
VIVIO Health named winner of 2019 Health Value Award for Specialty Drug Managers
04/30/2019
Read More ->
Four Policy Solutions That Would Bring Fairness to Drug Pricing
article originally published by Validation Institute, Pramod John
11/01/2018
Read More ->
CVS, Cigna Deals Could Thwart Nascent Pharmacy Benefit Services to higher prices
quoted in Bloomberg Big Law Business, PRAMOD JOHN
10/11/2018
Read More ->
Imagine there are no PBMs. It’s easy if you try
article published in STAT, SALLY WELBORN and PRAMOD JOHN
08/23/2018
Read More ->
CHG’s Nicole Thurman featured in Managed Care Magazine
quoted in Bloomberg Big Law Business, CHG BLOG
08/06/2018
Read More ->
Data Analytics and Outcomes Based Models to Help Employers Control Their Specialty Drug Spend
interview by Michael Menerey, PRAMOD JOHN
07/24/2018
Read More ->
’60 Minutes’ Was Right About Huge Drug Prices, But Wrong About The Villain
Forbes article featuring CHG and VIVIO Health, LEAH BINDER
05/11/2018
Read More ->
VIVIO Health, One Year Later
Interview with Mabel Jong, World Congress Correspondent, at World Health Care Congress 2018, PRAMOD JOHN
04/29/2018
Read More ->
Preview: VIVIO Health’s 4/29/18 presentation at World Health Care Congress
interview by journalist Mabel Jong, PRAMOD JOHN
04/09/2018
Read More ->
Companies Looking Outside Government Oversight For Lower Drug Prices
interview by Bronson Teichert for Utah Public Radio, PRAMOD JOHN
03/13/2018
Read More ->
Cigna’s Express Scripts deal could lead to higher prices
quoted in MarketWatch, PRAMOD JOHN
03/09/2018
Read More ->
Cigna to buy Express Scripts in $67 billion deal
quoted in Modern Healthcare, PRAMOD JOHN
03/08/2018
Read More ->
3 Tips to Help Tame the M&A Beast
article published in BenefitsPRO, PRAMOD JOHN
02/23/2018
Read More ->
Challenging Oncology Therapies With Moonshot Price Tags
article originally published as a Lundberg Institute Blog, PRAMOD JOHN
12/13/2017
Read More ->
VIVIO Health is a Winner in TiE Award Competition
accepts achievement certificate and $2,500 prize from TiE Pittsburgh, T. J. TEDESCO
12/12/2017
Read More ->
Carving Out Specialty Pharmacy Benefits
interview by Stacey Richter for Relentless Health Value, PRAMOD JOHN
12/07/2017
Read More ->
What will the CVS-Aetna deal mean for consumers?
appearance on CNBC’s Capital Connection, interview by Nancy Hungerford, PRAMOD JOHN
12/04/2017
Read More ->
What if Amazon Breaks into the Pharmacy Business?
interview by Stacey Richter for Relentless Health Value, PRAMOD JOHN
11/02/2017
Read More ->
Potential CVS-Aetna merger: Key takeaways for health execs
quoted in Managed Healthcare Executive, PRAMOD JOHN
11/01/2017
Read More ->
A Test Case on Sanity of Drug Prices
article published in Insurance Thought Leadership, PRAMOD JOHN
09/18/2017
Read More ->
The Emperor’s New Clothes: Biosimilars and Cost in Oncology
article published on ASCO POST, KEVIN KNOPF, MD
07/10/2017
Read More ->
Why are Our Drugs so Expensive? And, what do Businesses Need to Know?
interview with Jeffrey Hayzlett, PRAMOD JOHN
06/29/2017
Read More ->
Unrigging the High Cost of Drugs
interview with Steve Ambrose of Red Hot Healthcare, PRAMOD JOHN
02/02/2017
Read More ->America’s Healthcare Challenge (AHC), Radio Appearance
AHC hosted by Sean McGuire, PRAMOD JOHN & T. J. TEDESCO
09/24/2016
Read More ->
Epi-Pen Pricing: It’s the System, Stupid
blog article published on LinkedIn, PRAMOD JOHN
08/29/2016
Read More ->Why Our Problem With Drug Pricing Goes Way Beyond Shkreli
blog article published on LinkedIn, PRAMOD JOHN
07/15/2016
Read More ->
Explaining Rising Drug Costs
blog article published In healthreform EXPLAINED, SEAN McGUIRE
07/11/2016
Read More ->America’s Healthcare Challenge (AHC), Radio Appearance
AHC hosted by Sean McGuire, PRAMOD JOHN
06/11/2016
Read More ->
©2023 VIVIO Health Inc. All rights reserved.